Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.69M $714.93M Sept. 30, 2015
ClearBridge Advisors 9.59M $610.35M March 31, 2015
Vanguard 8.81M $355.66M Sept. 30, 2015
BAILLIE GIFFORD & CO 7.90M $319.29M Sept. 30, 2015
BB Biotech AG 6.63M $268.18M Sept. 30, 2015
Waddell & Reed Financial 5.77M $233.24M Sept. 30, 2015
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
Artisan Partners Limited Partnership 3.85M $237.86M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 3.05M $123.19M Sept. 30, 2015
BlackRock Fund Advisors 2.79M $112.89M Sept. 30, 2015
T. Rowe Price Associates 2.68M $165.36M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 2.60M $100.91M Sept. 30, 2014
STATE STREET CORPORATION 2.50M $101.00M Sept. 30, 2015
EQUITEC SPECIALISTS 2.39M $2.39M Dec. 31, 2014
Tocqueville Asset Management 2.26M $23.63M Dec. 31, 2012

Who sold ISIS Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Gail Mannix March 31, 2011 2.39M $21.59M